Metraipolis › archive › dc_8a99590b151a

Oral Celastrol Nanomedicine Targeting Intestinal Antigen-Presenting Cells to Effectively Mitigate Autoimmune Uveitis via Gut-Retina Axis — Europe PMC PMID:41632039

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41632039
DOI
10.1002/advs.202519503
License (as archived)
solo-consultazione
Archived
2026-11-06T04:02:09.599Z
SHA-256 of the archived text
93c44bb86a06ef0144d16962f7fd3029688ba78cd0337967a47c1345d6582d51
Stable URL of this page
https://metraipolis.com/documento/dc_8a99590b151a

How to cite

Oral Celastrol Nanomedicine Targeting Intestinal Antigen-Presenting Cells to Effectively Mitigate Autoimmune Uveitis via Gut-Retina Axis — Europe PMC PMID:41632039 — Europe PMC (en), https://europepmc.org/article/MED/41632039 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a99590b151a (Metraipolis archive dc_8a99590b151a, sha256 93c44bb86a06ef0144d16962f7fd3029688ba78cd0337967a47c1345d6582d51)
BibTeX
@misc{dc8a99590b151a,
  title = {Oral Celastrol Nanomedicine Targeting Intestinal Antigen-Presenting Cells to Effectively Mitigate Autoimmune Uveitis via Gut-Retina Axis — Europe PMC PMID:41632039},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41632039},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a99590b151a; sha256 93c44bb86a06ef0144d16962f7fd3029688ba78cd0337967a47c1345d6582d51},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41632039. Agents can read the archived copy with the MCP tool read_document.